How Long Does 5 mg of Ambien Last in Your System?

A 5 mg dose of Ambien (zolpidem) typically produces its sleep-inducing effects for about four to six hours, with the drug’s elimination half-life ranging from roughly 1.5 to 3.2 hours in healthy adults.¹ That means the drug’s blood levels drop by half every couple of hours and are largely gone within a day, but “gone from your system” and “no longer affecting you” are not quite the same thing. How quickly your body clears a 5 mg dose depends on your sex, age, liver health, and what else you have taken alongside it.

What Happens After You Take a 5 mg Dose

Zolpidem reaches its peak concentration in the blood within about 45 minutes to two and a half hours after swallowing a tablet. From that peak, blood levels decline quickly. In a healthy adult, the terminal elimination half-life sits somewhere between 1.5 and 3.2 hours, meaning most of the active drug clears from the bloodstream within about eight to twelve hours of a single 5 mg dose.¹ At that point, any remaining traces are mostly inactive breakdown products rather than the parent compound doing anything meaningful to your brain.

The liver does the heavy lifting. Zolpidem is broken down primarily by a liver enzyme called CYP3A4, with smaller contributions from a handful of other enzymes.² Because the drug relies on multiple enzyme pathways rather than just one, blocking any single pathway does not dramatically slow things down. Researchers studying genetic variations in one of those secondary enzymes, CYP2C19, found no significant differences in the drug’s overall clearance, half-life, or total exposure among people with different genetic versions of that enzyme.³ Even when a CYP3A4 inhibitor was added on top of different CYP2C19 genotypes, the drug’s behavior barely budged. So for zolpidem, the worry about being a “poor metabolizer” based on common genetic tests is less relevant than it is for some other medications.

The Sex Gap in Clearance

This is a big deal and one reason the 5 mg dose exists in the first place. Women clear zolpidem from their bodies about 35% more slowly than men, with an average apparent clearance of roughly 236 mL/min versus 364 mL/min in men. That difference was not explained by body weight.⁴ In practical terms, a woman taking the same dose as a man will have higher blood levels the following morning, which is why the FDA in 2013 changed its labeling to recommend that women start at 5 mg of immediate-release zolpidem rather than 10 mg.

The mechanism behind this gap is not entirely pinned down, but it likely involves sex-related differences in how liver enzymes express themselves and how the drug distributes through body tissue. Regardless of the underlying reason, the bottom line for women is that a 5 mg dose acts somewhat like a proportionally larger dose. If you are a woman wondering whether a 5 mg pill will still be affecting you six or seven hours after you take it, the honest answer is that residual effects are more likely for you than for a man who took the same pill at the same time.

How Age Changes the Equation

Getting older slows zolpidem clearance in both sexes, but the pattern is a little different for men and women. In one study comparing young and elderly adults, men showed a sharp decline in clearance with age: from about 11.0 mL/min/kg in younger men to 3.8 mL/min/kg in older men, with peak blood concentrations more than doubling and the half-life climbing from 1.5 hours to 2.7 hours. Women also showed reduced clearance with age (5.8 to 3.0 mL/min/kg) and higher peak concentrations, but interestingly their half-life barely changed between younger and older groups.⁵

What stands out from this data is that an older man’s clearance can drop into the same range as a younger woman’s, which means older men face a similarly extended drug exposure. The researchers speculated that declining testosterone might play a role in the age-related slowdown in men, given that testosterone is known to influence certain liver enzyme activity. For anyone over 65, the standard prescribing recommendation is to start at 5 mg rather than 10 mg, precisely because the drug hangs around longer.

Liver Disease Can Multiply the Duration Dramatically

If there is one situation where zolpidem’s timeline changes from “a few hours” to “an entire day,” it is liver impairment. In patients with cirrhosis, the mean half-life of zolpidem ballooned to 9.9 hours, with individual values ranging from about 4 to nearly 26 hours. For comparison, the normal half-life in healthy adults is around 2.2 hours.⁶ That kind of range means a person with significant liver disease could still have meaningful drug levels in their blood well into the next afternoon from a bedtime dose. For these patients, the recommended dose is 5 mg, and even that should be used cautiously.

You do not need full-blown cirrhosis for this to matter. Any condition that meaningfully reduces liver function, including fatty liver disease or hepatitis with active inflammation, could slow clearance to some degree. If you are on zolpidem and have known liver problems, your doctor should be aware, because the “standard” timeline of the drug leaving your system may not apply to you at all.

Alcohol and Drug Interactions

Mixing zolpidem with alcohol is one of the most common and most dangerous ways people accidentally extend and intensify its effects. Research on the pharmacodynamic interaction found that in the presence of alcohol, the concentration of zolpidem needed to produce its sedative effect dropped to roughly half of what it would normally take. In other words, alcohol effectively doubles the drug’s punch at any given blood level.⁷ This is not about alcohol slowing the drug’s elimination; it is about both substances amplifying each other’s effect on the same brain receptor system. The drug may clear on its usual schedule, but while it is active, you are far more sedated than the blood level alone would predict.

Because zolpidem is primarily metabolized through CYP3A4, drugs that inhibit that enzyme can slow clearance. Common CYP3A4 inhibitors include certain antifungal medications, some antibiotics, and grapefruit juice in large quantities. That said, because zolpidem also uses backup enzyme pathways, the effect of a single CYP3A4 inhibitor tends to be more moderate than you might see with drugs that depend entirely on that one enzyme.² On the flip side, CYP3A4 inducers like rifampin can speed metabolism and potentially make the drug less effective. If you are taking any medication that your pharmacist flags as a CYP3A4 interaction, it is worth asking whether your zolpidem dose or timing needs adjusting.

Next-Morning Driving and Residual Impairment

The reason any of this matters beyond academic curiosity is what happens when you get behind the wheel the morning after taking Ambien. Even with a short half-life, residual sedation can persist long enough to impair driving ability. A driving study using sublingual zolpidem at 3.5 mg (a lower dose than the 5 mg oral tablet) found that driving performance was measurably impaired when people drove three hours after dosing, with a significantly higher proportion of drivers classified as impaired. By four hours, the proportion of impaired drivers was no longer statistically elevated, though a small measurable effect on lane weaving still existed.⁸

A separate study looked at driving after a full bedtime dose of 10 mg zolpidem and found significant impairment on road tests the following morning.⁹ This is worth noting because a 5 mg dose falls between these two study conditions. If you take 5 mg at bedtime and sleep a full seven to eight hours, you will likely be past the worst of the residual effects, but “likely” is doing real work in that sentence. Women, older adults, and anyone with slower metabolism should build in extra buffer time. The general guidance is to allow at least seven to eight hours between taking the drug and doing anything that requires full alertness, and not to take it if you cannot commit to that window.

How Long Drug Tests Can Detect Zolpidem

Zolpidem does not show up on standard workplace drug panels, which typically test for substances like amphetamines, opioids, cannabinoids, cocaine, and benzodiazepines. Although zolpidem acts on a similar brain receptor as benzodiazepines, it is a structurally different compound and does not cross-react on most immunoassay screens designed for benzodiazepines. However, specialized testing that specifically targets zolpidem or its metabolites can detect it, and this kind of testing does come up in forensic, legal, and certain clinical settings.

In urine, zolpidem and its metabolites can be found for a surprisingly long time relative to its short half-life. One study found that two out of a group of patients still had zolpidem concentrations at or above 10 ng/mg creatinine more than 20 hours after a dose.¹⁰ This is not because the drug is still active in the brain at that point; it reflects the fact that metabolites continue to wash out through the kidneys well after the parent compound has cleared the bloodstream.

In oral fluid (saliva), zolpidem was detectable for up to 15 hours after a 10 mg dose.¹¹ For a 5 mg dose, you would expect a shorter detection window, but researchers have also developed methods to detect both the parent drug and its metabolite in oral fluid after single doses, which has applications in roadside impairment testing and drug-facilitated assault investigations.¹² In blood, the detection window roughly mirrors the active phase of the drug, on the order of six to twelve hours depending on the individual and the sensitivity of the assay.

If you take Ambien as prescribed and need to take a drug test for work, you generally have nothing to worry about. If you are in a situation where targeted forensic testing might be applied, such as a DUI investigation, the drug can be found in your system well past the point where you feel its effects.

Immediate-Release Versus Extended-Release Formulations

The 5 mg dose most people ask about is the immediate-release (IR) tablet, but it is worth understanding how it differs from the extended-release version (Ambien CR), because the two have meaningfully different timelines. The extended-release formulation has a more prolonged pharmacodynamic effect than the immediate-release version and is specifically designed to address wake-ups in the middle of the night, not just difficulty falling asleep.¹³

The extended-release tablet uses a two-layer design. One layer dissolves quickly to help you fall asleep, and the second layer releases more slowly to maintain drug levels through the night. The result is a longer period of effective blood levels compared to the IR tablet, which means the residual morning effects also last longer. If you are taking extended-release zolpidem and wondering about morning impairment or detection windows, you should expect everything discussed above to shift later by roughly an hour or two compared to the immediate-release version. The extended-release tablets come in 6.25 mg and 12.5 mg strengths rather than 5 mg and 10 mg, so the dosing is not directly interchangeable.

What Happens When You Stop Taking It

A common worry with sleep medications is rebound insomnia, the phenomenon where stopping the drug temporarily makes your sleep worse than it was before you started. With zolpidem, the evidence on this is more reassuring than many people expect. A year-long study of nightly zolpidem use found that rebound insomnia was not observed on the first two nights after discontinuation or on the seventh night off the drug. Some individuals did experience worse sleep after stopping, but this happened in roughly equal proportions (about 30 to 40 percent) in both the zolpidem group and the placebo group, meaning it was not a drug-specific withdrawal effect.¹⁴

This does not mean dependence never happens. People who take high doses, use the drug for extended periods outside of clinical guidance, or combine it with other sedatives can develop tolerance and withdrawal effects. But at a therapeutic 5 mg dose used as directed, the evidence suggests that the drug clears without leaving a meaningful pharmacological hangover in terms of worsened sleep. The bigger issue for most people is the psychological habit: if you have relied on a pill to fall asleep for months, the anxiety of not having it can itself keep you awake, which looks and feels like rebound but is not the same thing mechanistically.

Factors That Do Not Matter as Much as You Might Think

Given how much attention genetic testing has received in recent years, you might assume that your personal genetic makeup would strongly predict how long zolpidem lasts in your system. For some drugs, that is true. For zolpidem, the evidence is underwhelming. The study on CYP2C19 genetic variants found that neither the drug’s total exposure, half-life, nor clearance differed significantly among people with normal, intermediate, or poor metabolizer genotypes for that enzyme.³ Because CYP3A4 handles most of the work and the drug has redundant metabolic pathways, individual genetic variation in the secondary enzymes does not translate into a big difference in how long the drug sticks around.

Body weight is another factor people assume matters more than it does. The sex difference in clearance persisted even after adjusting for body weight, suggesting that a heavier man and a lighter woman do not simply process the drug in proportion to their size.⁴ While extreme obesity could theoretically alter drug distribution by changing the ratio of fat to lean tissue, the research to date does not point to body weight as a primary driver of how long a 5 mg dose of Ambien stays active. Sex, age, and liver function are the variables that reliably move the needle.